FEATURES OF DIAGNOSIS AND ADVERSE COURSE OF NEONATAL JUVENILE XANTHOGRANULOMA: CASE REPORT
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-4.19193Keywords:
histopathological, immunohistochemical method, neonatal systemic juvenile xanthogranulomaAbstract
The work describes a case of rare neonatal systemic juvenile xanthogranuloma with an initial damage of the scalp, limbs, back and abdomen, multiple damages of the parenchyma of both lungs, spleen and liver with the development of a severe form of congenital cholestatic hepatitis. The diagnosis was established on the basis of histopathological and immunohistochemical examination of the skin nodules. The child on the background of therapy under the Langerhans cell histiocytosis III program achieved a partial response, which was manifested by a reduction of granulomatous formations on the skin, elimination of liver failure, but retained hepatosplenomegaly, specific lesions of the lung parenchyma, liver, and left kidney. Against the background of cytostatic therapy, the patient developed secondary pancytopenia, perianal ulcerative-necrotic dermatitis with lesions on buttocks, stomatitis, protein-energy deficiency, acute liver failure. coagulopathy, disseminated intravascular coagulation syndrome, acute renal failure, respiratory failure of III degree, cardiovascular insufficiency of III degree, pulmonary edema, cerebral edema, cerebral coma of II–III degree, enterocolitis, intestinal paresis. Despite multicomponent intensive care, the child’s condition progressively deteriorated, and the patient died. The aspects of differential diagnosis of neonatal systemic juvenile xanthogranuloma are discussed.
References
Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel Pediatric Tumor Registry. Am J Surg Pathol 2005; 29: 21–8. doi: https://doi.org/10.1097/01.pas.0000147395.01229.06
Bakir B, Unuvar E, Terzibasioglu E, et al. Atypical lung involvement in a patient with systemic juvenile xanthogranuloma. Pediatr Radiol 2007; 37: 325–7. doi: https://doi.org/10.1007/s00247-006-0396-7
Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003; 27: 579–93.
Freyer DR, Kennedy R, Bostrom BC, et al. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr 1996; 129: 227–37. doi: https://doi.org/10.1016/S0022-3476(96)70247-0
Rodríguez-Velasco A, Rodríguez-Zepeda MDC, Ortiz-Hidalgo C. Infantile systemic juvenile xanthogranuloma case with massive liver infiltration. Autops Case Rep 2019; 9: e2018081. doi: https://doi.org/10.4322/acr.2018.081
Nascimento AG. A clinicopathologic and immunohistochemical comparative study of cutaneous and intramuscular forms of juvenile xanthogranuloma. Am J Surg Pathol 1997; 21: 645–52. 10.1097/00000478-199706000-00003
Chantranuwat C. Systemic form of juvenile xanthogranuloma: Report of a case with liver and bone marrow involvement. Pediatr Dev Pathol 2004; 7: 646–8. 10.1007/s10024-004-1012-1
Karcioglu ZA, Sharara N, Boles TL, et al. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthal Plast Reconstr Surg 2003; 19: 372–81. doi: https://doi.org/10.1097/01.IOP.0000083642.15174.83
Murphy JT, Soeken T, Megison S, et al. Juvenile xanthogranuloma: diverse presentations of noncutaneous disease. J Pediatr Hematol Oncol 2014; 36: 641–5. doi: https://doi.org/10.1097/MPH.0000000000000027
Chantorn R, Wisuthsarewong W, Aanpreung P, et al. Severe congenital systemic juvenile xanthogranuloma in monozygotic twins. Pediatr Dermatol 2008; 25: 470–3. doi: https://doi.org/10.1111/j.1525-1470.2008.00752.x
Cusick EL, Spicer RD. Juvenile xanthogranuloma with extra-cutaneous lesions — a case report. Eur J Pediatr Surg 1994; 4: 368–9. doi: https://doi.org/10.1055/s-2008-1066137
Diard F, Cadier L, Billaud C, et al. Neonatal juvenile xanthogranulomatosis with pulmonary, extrapleural and hepatic involvement. One case report. Ann Radiol (Paris) 1982; 25: 113–8.
Guthrie JA, Arthur RJ. Case report: juvenile xanthogranuloma with pulmonary, subcutaneous and hepatic involvement. Clin Radiol 1994; 49: 498–500. doi: https://doi.org/10.1016/S0009-9260(05)81751-9
Haughton AM, Horii KA, Shao L, et al. Disseminated juvenile xanthogranulomatosis in a newborn resulting in liver transplantation. J Am Acad Dermatol 2008; 58: S12–5. doi: https://doi.org/10.1016/j.jaad.2007.09.012
Takeuchi M, Nakayama M, Nakano A, et al. Congenital systemic juvenile xanthogranuloma with placental lesion. Pediatr Int 2009; 51: 833–6. doi: https://doi.org/10.1111/j.1442-200X.2009.02932.x
Fan R, Sun J. Neonatal systemic juvenile xanthogranuloma with an ominous presentation and successful treatment. Clin Med Insights Oncol 2011; 5: 157–61. doi: https://doi.org/10.4137/CMO.S6686
Mudambi K, Berquist W. “Blueberry muffin” rash and neonatal cholestatic liver failure. Dig Dis Sci 2018; 63: 1747–50. doi: https://doi.org/10.1007/s10620-017-4810-9
Nakatani T, Morimoto A, Kato R, et al. Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy. J Pediatr Hematol Oncol 2004; 26: 371–4. doi: https://doi.org/10.1097/00043426-200406000-00007
Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer 2005; 45: 256–64. doi: https://doi.org/10.1080/08820530500351769
Isaacs HJr. Fetal and neonatal histiocytoses. Pediatr Blood Cancer 2006; 47: 123–9. https://doi.org/10.1002/pbc.20725
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
